Sign Up for Our E-Newsletter

In The News

5 Takeaways to Managing Side Effects

Posted on September 7, 2016


Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in your healthcare management.

Last month, our webinar focused on working with your doctor to manage your side effects. Couldn’t make the webinar? Get our Top 5 Takeaways below and watch the replay. Read more

INFOGRAPHIC: What You Said about Research

Posted on September 6, 2016

Last month, we debuted a survey asking you, our Colon Cancer Alliance friends and family, what you thought was worth investing in. Nearly 200 of you filled out the questions, telling us what you thought was important to you, and what you’d like to see us prioritize. Thank you to all of you who took the time to respond!

Here’s what you said. Read more

Cancer Moonshot Initiative Fosters Breakthrough Collaboration

Posted on June 29, 2016


Release of More Current Clinical Trials Data Gives Patients Access to Better Information Faster

Today, we announced our breakthrough collaboration with online patient community Smart Patients on a free Clinical Trials Database and online community for patients with colorectal cancer. These tools use data from—made available today by the National Cancer Institute (NCI) as part of the Cancer Moonshot Summit hosted by Vice President Biden in Washington, DC. Smart Patients was selected by the NCI and the VP’s office to receive early access to this new data in order to provide feedback and incorporate the data into the Smart Patients online patient community.

Read more

BREAKING: USPSTF Responds to Concerns, Releases Final Screening Report

Posted on June 16, 2016


The Colon Cancer Alliance applauds the final report from the U. S. Preventive Services Task Force (USPSTF) on screening for colorectal cancer.

First and foremost, the USPSTF has maintained its “A” grade to screening for colorectal cancer; recognizing the high level of certainty that screening reduces colorectal cancer mortality and recommending that adults between the ages of 50 and 75 get timely screening.

Secondly, the final report resolves the concerns we expressed regarding several items in the initial draft report, including labeling some screening methods as “recommended” and others as “alternative.”

We specifically named these tests in our concerns as a major barrier to screening for Americans, and we applaud the USPSTF for widening its inclusion for these newer and proven tests.

Read more

Into the Weeds: What You Need to Know About Medical Marijuana & CRC Part III

Posted on May 18, 2016

into the weeds - Blog Graphic

While the use of marijuana has been around for thousands of years, it has only become legal in 24 states and the District of Columbia within recent history. As more states continue to approve marijuana for medical purposes, it’s important to separate the myths from the facts surrounding this drug.

This blog is the third in this series. Read Part I and Part II.

Research Studies

Cannabis research policies vary across the world. For example, Canada and the Netherlands have government-run programs in which specialized companies supply quality-controlled herbal cannabis. The Czech Republic, Israel, Canada and the Netherlands have government-sponsored research programs. 

Read more